EValuate Diagnostics utilizes circulating extracellular vesicles to purify and identify tumor biomarkers, enabling early and non-invasive cancer detection. This technology enhances diagnostic accuracy, facilitating timely disease intervention and improving patient outcomes.

KayoThera develops first-in-class oral small molecules that inhibit the retinoid and rexinoid nuclear receptor pathways, which are linked to adverse outcomes in late-stage cancers and cardiometabolic diseases. By blocking the formation of retinoid ligands, KayoThera provides new therapeutic options for managing diabetes, obesity, and cancer.

Oculomotor Technologies provides a vision therapy tool that utilizes onboard eye tracking and virtual reality games to treat convergence insufficiency in patients. This solution enhances patient engagement while delivering real-time performance analysis to tailor therapy for individual needs.

Tino is a B2B payments platform that provides SMB retailers with flexible payment options, allowing them to purchase from suppliers and defer payments while managing their cash flow effectively. By aggregating invoices into a single payment and offering extended credit terms, Tino simplifies financial management for small businesses.

Visikol is a contract research organization specializing in digital pathology, 3D tissue imaging, and 3D cell culture assays, providing pharmaceutical and biotech companies with tools to enhance drug discovery efficiency. Their services enable researchers to obtain critical insights into drug efficacy and safety, reducing the time and cost associated with traditional development processes.

Develops therapeutics for mental health and addiction disorders, focusing on preventing overdose fatalities through targeted drug design. The approach prioritizes patient safety by addressing medication misuse and improving treatment outcomes.